Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): defining and measuring functional impacts in pediatric patients
Abstract Background Research about pediatric patients’ perspective on mucopolysaccharidosis type VI (MPS VI) and its impact on daily life is limited. We aimed to identify the disease concepts of interest that most impact function and day-to-day life of pediatric patients with MPS VI, and to consider...
Guardado en:
Autores principales: | Beth Leiro, Dawn Phillips, Melanie Duiker, Paul Harmatz, Sharon Charles |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6d91072cc7f44da8bb9faffaabf22b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase
por: Regina P El Dib, et al.
Publicado: (2009) -
Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II
por: Karen S. Yee, et al.
Publicado: (2021) -
Illness perception and clinical treatment experiences in patients with M. Maroteaux-Lamy (mucopolysaccharidosis type VI) and a Turkish migration background in Germany.
por: Hansjörg Dilger, et al.
Publicado: (2013) -
Diagnostic imaging in patients with mucopolysaccharidosis: important imaging patterns
por: Igor I. Yarmola, et al.
Publicado: (2021) -
Hyo-Mental Angle and Distance: An Important Adjunct in Airway Assessment of Adult Mucopolysaccharidosis
por: Chaitanya Gadepalli, et al.
Publicado: (2021)